Sunny Pharmtech Inc. (TPEX:6676)
13.50
-0.25 (-1.82%)
Jul 4, 2025, 1:39 PM CST
Sunny Pharmtech Revenue
In the year 2024, Sunny Pharmtech had annual revenue of 418.01M TWD, down -2.52%. Sunny Pharmtech had revenue of 184.45M in the half year ending December 31, 2024, a decrease of -9.67%.
Revenue
418.01M
Revenue Growth
-2.52%
P/S Ratio
4.84
Revenue / Employee
2.71M
Employees
154
Market Cap
2.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 418.01M | -10.82M | -2.52% |
Dec 31, 2023 | 428.83M | 69.24M | 19.26% |
Dec 31, 2022 | 359.59M | 118.59M | 49.21% |
Dec 31, 2021 | 241.00M | -178.94M | -42.61% |
Dec 31, 2020 | 419.94M | 185.46M | 79.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 40.47M |
PharmaEssentia | 11.34B |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Oneness Biotech | 117.33M |
Center Laboratories | 1.63B |
TaiMed Biologics | 607.46M |